← All Nasus Pharma LTD filings

Nasus Pharma LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

AMEX
NSRX
Nasus Pharma LTD
Form 4: Nasus Pharma CFO Reports Stock Transaction
Eyal Rubin, Chief Financial Officer of Nasus Pharma Ltd, reported multiple transactions in common stock on September 18, 2026.
AMEX
NSRX
Nasus Pharma LTD
Form 4: Nasus Pharma CEO Reports Stock Transaction
Dan Benjamin Teleman, Chief Executive Officer and a Director of Nasus Pharma Ltd, reported multiple transactions in common stock on July 22, 2026.
AMEX
NSRX
Nasus Pharma LTD
Form 4: Nasus Pharma CEO Dan Teleman Increases Equity Stake
CEO Dan Benjamin Teleman purchased 2,900 ordinary shares of Nasus Pharma Ltd at $3.76 per share, signaling executive confidence.
AMEX
NSRX
Nasus Pharma LTD
Form 4: Nasus Pharma CEO Boosts Stake with $30.6K Share Purchase
Nasus Pharma Ltd's CEO, Dan Benjamin Teleman, acquired 15,000 ordinary shares at $2.04 each, increasing his direct beneficial ownership.